Kintsugi

health AImental healthmedtech

Visit website LinkedIn ↗

StageSeries A

Raised$30.14M

Founded2019

Employees12

LocationBerkeley, CA

Business modelB2B, SaaS

About

Kintsugi is on a mission to scale access to mental healthcare for all. We are developing FDA-bound novel voice biomarker AI to detect signs of clinical depression and anxiety from short clips of sound. Awarded multiple distinctions for AI technology and recently named one of Forbes’ Top 50 AI, Fierce 15, and World Economic Forum’s Innovation Pioneers, Kintsugi helps to close mental health quality and care gaps across healthcare. At Kintsugi, we believe that mental health is just as important as physical health. We exist to ensure that everyone who needs mental healthcare has access to the right care at the right time. See mental health differently with Kintsugi. To learn more: https://www.kintsugihealth.com

Product

Value proposition: Provides objective, quantifiable mental health screening and on-call mental health data through voice biomarker technology integrated with healthcare platforms to improve care delivery for patients with mental health disorders
Target customers: providers, payers, healthcare organizations

Founders

Grace Chang — Founder/CEO
Rima Seiilova-Olson — Co-founder and machine learning scientist

Products

Kintsugi VoiceKintsugi ConnectKintsugi AppKintsugi Voice biomarker platform

Key features

voice biomarker technologyunbiased data captureintegration with Pega platform for on-call mental health dataquantifiable mental health screeningAI governance and responsible AI features

Technologies

voice biomarkerAI governanceprivacy/complianceunbiased data collection

Integrations

Pega platformEHRs / healthcare IT systems

Target conditions

mental health disordersmental health in pediatrics

Care settings

inpatientoutpatientvirtualclinical settingson-call/telehealth

Awards

Gartner Cool Vendor 2022 in AI Governance and Responsible AIFrost & Sullivan 2022 North American Vocal Biomarkers for Mental Health Technology Innovation Leadership AwardBuiltIn Fully Remote Best Startups to Work 2023CB Insights Digital Health 150

Traction metrics

recognition by CB Insights Digital Health 150Gartner Cool Vendor 2022Frost & Sullivan award 2022BuiltIn Best Places to Work 2023

Investors

Insight PartnersAcrew CapitalDarling VenturesCitta CapitalSide Door VenturesPrimetime PartnersIT-FarmAngelList FundAlpha EdisonTechstarsOn DeckEric YuanAdam GrosserNational Science FoundationMicrosoft for Startups Pegasus Program

News

It’s not easy to get depression-detecting AI through the FDA | The Verge · 2026-04-02T15:33:23.000Z
Why clinical AI startup Kintsugi shut down · 2026-02-18T20:43:12.000Z
Mental Health Voice Biomarker Kintsugi Closes, Makes All Technology and Research Public - Behavioral Health Business · 2026-02-11T20:03:38.000Z
When a health tech startup gets stuck in regulatory limbo · 2026-02-19T19:16:19.000Z
Depression-Detecting AI Startup Kintsugi Shuts Down After FDA Rejection - Startup Fortune · 2026-04-02T10:05:51.000Z
How FDA’s $1 million approval costs prompt Kintsugi to open source voice biomarker AI - THE RED ROBOT · 2026-02-13T10:49:36.000Z

Browse similar startups

Related startups

Kismet Health Inc — Oakland, CA
LOS ANGELES REPRODUCTIVE CENTER — Encino, CA
Maarge — San Jose, CA
Malibu Medical — Malibu, CA
Marvin Behavioral Health — los angeles, CA
MD Synergy Solutions, LLC — Calabasas, CA
Kitsa — Summit, NJ
Klayon Therapeutics — Carmel, IN
KNOWN — chicago, IL
Krystal Vision Eye Care — Philadelphia, PA
LearnYour Benefits — Plymouth, MN
Lehigh Valley Oral Surgery and Implant Center — Bethlehem, PA

Profile updated Jul 29, 2026. Sources: kintsugihealth.com, builtin.com, annfammed.org